LAZARUS ROCHELLE B 4
4 · Organon & Co. · Filed Jun 8, 2021
Insider Transaction Report
Form 4
LAZARUS ROCHELLE B
Director
Transactions
- Award
Phantom Stock
2021-06-04$36.05/sh+8,772$316,231→ 8,772 total→ Common Stock (8,772 underlying)
Holdings
- 460
Common Stock
- 175(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]Shares acquired in a pro rata distribution by Merck & Co., Inc. ("Merck") of shares of Organon & Co. ("Organon") in connection with the separation of Organon from Merck (the "Separation").
- [F2]1-for-1
- [F3]Consists of (i) a one-time grant of 5,549 phantom units awarded in connection with the Separation, which units will vest in full on the earlier of the one-year anniversary of the Separation or Organon's first annual shareholders meeting after the Separation, and (ii) a pro-rata portion of the annual equity retainer in the form of 3,223 phantom units, which units are fully vested. Phantom units are granted under the Organon Non-Employee Director Savings Plan and are payable in cash upon settlement no sooner than one year after service as a director ceases.